XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2Close
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses    
Cost of product revenue $ 430 $ 345
Research and development 4,312 4,775
Sales and marketing 1,443 1,884
General and administrative 4,381 4,813
Total operating expenses 10,566 11,817
Loss from operations (8,215) (9,845)
Interest expense (611) (2,181)
Change in fair value of freestanding and hybrid financial instruments designated at Fair Value Option (2,021) (359)
Gain on extinguishment of debt 1,245  
Other income (expense) 234 (12)
Loss before income tax (9,368) (12,397)
Income tax expense 0 0
Net loss (9,368) (12,397)
Net loss attributable to noncontrolling interest (142) (195)
Net loss attributable to common stockholders $ (9,226) $ (12,202)
Net loss per share, basic $ (0.06) $ (2.39)
Net loss per share, diluted $ (0.06) $ (2.39)
Weighted-average common stock outstanding, basic 158,842,297 5,109,609
Weighted-average common stock outstanding, diluted 158,842,297 5,109,609
Product revenue, net    
Revenue    
Revenue $ 2,351 $ 1,972 CloseClose